Диссертация (1174297), страница 18
Текст из файла (страница 18)
Смирнова// Consilium Medicum. Педиатрия. – 2006. – 01. – с.112-118.29. Тамразова, О.Б. Возможности преодоления антибиотикорезистентности втерапии пиодермий/ О.Б. Тамразова//Клиническая дерматология ивенерология. – 2014. – 6. – с. 64-73.30. Тамразова, О.Б. Препараты серебра в лечении пиодермий. / О.Б. Тамразова//Клиническая дерматология и венерология. – 2014. – 3. – с. 46-43.31.
Текучева, Л. В. Терапия детей, больных атопическим дерматитом, с учетомстепени бактериальной обсемененности кожи и тяжести течениязаболевания: автореф. дис. на соиск. учен. степ. канд. мед.наук: 14.00.11 / Текучева Лилиана Владимировна — Москва, 2009 г. — 22 с.32. Феденко, Е.С. Роль грибковой инфекции в развитии атопическогодерматита и целесообразность противогрибковой терапии. / Е.С. Феденко,О.Г.
Елисютина // Росс. аллергол. журнал. – 2006. – 5. – с. 4–13.33. Флуер, Ф.С. Стафилококки и их энтеротоксины как фактор рискавозникновения атопического дерматита/Ф.С. Флуер // Педиатрия. – 2014. –93(3). – с. 124-129.34. Akdis, C.A.
Diagnosis and treatment of atopic dermatitis in children and adults:European Academy of Allergology and Clinical Immunology. AmericanAcademy of Allergy, Asthma and Immunology. PRACTALL Consensus ReportC. / C.A. Akdis, M. Akdis//A. Allergy. – 2006. – 61. P. 969–987.35. Alderson, M.R. Fas ligand mediates activation-induced cell death in human Tlymphocytes.
/ M.R. Alderson, T.W. Tough, T. Davis-Smith, S. Braddy, B. Falk,115K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, D.H. Lynch, //J. Exp.Med. – 1995. – 181. P. 71–77.36. Alonzo, F. 3rd. CCR5 is a receptor for Staphylococcus aureus leukotoxin ED/ F.3rd. Alonzo, L. Kozhaya, S.A. Rawlings, T. Reyes-Robles, A.L. DuMont, D.G.Myszka, N.R. Landau, D. Unutmaz, V.J.Torres// Nature. – 2013. – Jan 3.493(7430). P. 51-5.
doi: 10.1038/nature11724. Epub 2012 Dec 12.37. Aman, M. J. Staphylococcal bicomponent pore-forming toxins: targets forprophylaxis and immunotherapy/M.J. Aman, R.P. Adhikari//Toxins (Basel). –2014. – Mar 4. 6(3). P. 950-72. doi: 10.3390/toxins6030950.38. Anderson, M.J. Efficacy of skin and nasal povidone-iodine preparation againstmupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureuswithin the anterior nares. / M.J. Anderson, M.L. David, M. Scholz, S.J.
Bull, D.Morse, M. Hulse-Stevens, M.L. Peterson // Antimicrob Agents Chemother. –2015. – 59(5). – P. 2765-73. doi: 10.1128/AAC.04624-14. Epub 2015 Mar 2.39. Argudín, M. Food Poisoning and Staphylococcus aureus Enterotoxins/ M.Argudín, M. Mendoza, M. Rodicio//. Toxins. – 2010. – 2(7), P. 1751-1773.40. Arora, S. Cellular responses induced by silver nanoparticles: In vitro studies.
/ S.Arora, J. Jain, J.M. Rajwade, K. M. Paknikar // Toxicol. Lett. – 2008. – 179. P.93-100.41. Bachert, C. Chronic rhinosinusitis and asthma: novel understanding of the role ofIgE ‘above atopy/ C. Bachert, N. Zhang// J Intern Med. – 2012. – 272. P. 133–143.42. Bachert, C. Ige to Staphylococcus aureus enterotoxins in serum is related toseverity of asthma/ C. Bachert, P. Gevaert, P. Howarth, G. Holtappels, P.
vanCauwenberge, S.G. Johansson// J Allergy Clin Immunol. – 2003. – 111. P. 1131–1132.43. Baochen, Shi. The skin microbiome is different in pediatric versus adult atopicdermatitis/Shi. Baochen, J. Nathanael, B.S. Bangayan, Emily Curd, Patricia A.116Taylor, Richard L. Gallo, Donald Y.M. Leung, Huiying Li // Journal of Allergyand Clinical Immunology. – 2016. – Volume 138. Issue 4.
P.1233 – 1236.44. Berry, D. Pierre-Francois Olive Rayer: Biography/ D. Berry// Med Hist Suppl. –2005. – P. 7-13.45. Bessa, G.R.Staphylococcus aureus resistance to topical antimicrobials in atopicdermatitis./ G.R. Bessa, V.P. Quinto, D.C.
Machado, C. Lipnharski M.B.Weber, R.R. Bonamigo, P.A. D'Azevedo// An Bras Dermatol. – 2016. – 91(5). P.604-610. doi: 10.1590/abd1806-4841.2016486046. Bieber, T. Human epidermal langerhans cells express the high affinity receptorfor immunoglobulin E (Fc epsilon RI)/ T. Bieber, H. de la Salle, A.Wollenberg, J.
Hakimi, R. Chizzonite, J. Ring, D. Hanau, C. de la Salle//J ExpMed. – 1992. – 175. P.1285–1290.47. Bin, L. Staphylococcus aureus alpha-toxin modulates skin host response to viralinfection/ L. Bin, B.E. Kim, A. Brauweiler, E. Goleva, J. Streib, Y. Ji, P.M.Schlievert, D.Y. Leung// J. Allergy Clin. Immunol. – 2012. – 130. P. 683– 691.48. Boguniewicz, M.
Recent Insights into atopic dermatitis and implications formanagement of infectious complications. / M. Boguniewicz, D.Y. Leung//JAllergy Clin Immunol. – 2010. – 125(1). P. 4-13; quiz 14-5. doi:10.1016/j.jaci.2009.11.027. Review.49. Brattsand, M. A proteolytic cascade of kallikreins in the stratum corneum. / M.Brattsand, K. Stefansson, C. Lundh, Y. Haasum, T. Egelrud// J Invest Dermatol. –2005. – 124. P. 198-203.50. Broccardo, C.J.
Comparative proteomic profiling of patients with atopicdermatitis based on history of eczema herpeticum infection and Staphylococcusaureus colonization. / C.J. Broccardo, S. Mahaffey, J. Schwarz, L. Wruck, G.David, P.M. Schlievert, N.A. Reisdorph, D.Y. Leung//J. Allergy Clin.
Immunol.– 2011. – 127. P. 186 –193.51. Brunner, P.M. Increasing comorbidities suggest that atopic dermatitis is asystemic disorder. /P.M. Brunner, J.I. Silverberg, E. Guttman-Yassky, A.S.117Paller, K. Kabashima, M. Amagai, T.A. Luger, M. Deleuran, T. Werfel,K. Eyerich, G.Stingl// J Invest Dermatol. – 2017. – 137. P. 18-25.52. Bunikowski, R. Prevalence and role of serum IgE antibodies to theStaphylococcus aureus-derived superantigens SEA and SEB in children withatopic dermatitis/R. Bunikowski, M. Mielke, H. Skarabis, U.
Herz, R.L.Bergmann, U. Wahn, H. Renz//J. Allergy Clin. Immunol. – 1999. – 103. P. 119 –124.53. Candi, E. Transglutaminase cross-linking properties of the small proline-rich 1family of cornified cell envelope proteins integration with loricrin/ E. Candi, E.Tarcsa, W.W. Idler, T. Kartasova, L.N. Marekov, P.M. Steinert // J Biol Chem.
–1999. – 274. P. 7226-37.54. Carbone, A. Pediatric atopic dermatitis: a review of the medical management /A.Carbone, A. Siu, R. Patel //Ann Pharmacother. – 2009. – Vol.44. – Р.1448-1458.55. Carpaij, N. Genetic variation in spatio-temporal confined USA300 communityassociated MRSA isolates: a shift from clonal dispersion to genetic evolution? /N. Carpaij, R.J. Willems, T.W.
Rice, R.A. Weinstein, J. Hinds, A.A. Witney, J.A.Lindsay, M.J. Bonten, A.C. Fluit// PLoS ONE. – 2011. – 6, e1641956. Castanheira, M. Fusidic acid resistance rates and prevalence of resistancemechanisms among Staphylococcus spp. isolated in North America and Australia,2007– 2008 /M. Castanheira, A.A. Watters, J.M. Bell, J.D. Turnidge, R.N. Jones//Antimicrob Agents Chemother. – 2010. – 54. P. 3614–7.57. Cavalcante, F. S. High prevalence of methicillin resistance and PVL genesamong Staphylococcus aureus isolates from the nares and skin lesions of pediatricpatients with atopic dermatitis.
/ F.S. Cavalcante, E.D. Abad, Y.C. Lyra, S.B.Saintive, M. Ribeiro, D.C. Ferreira, K.R. Santos // Braz J Med Biol Res. – 2015.– 48(7). – P. 588-94. doi: 10.1590/1414-431X20154221. Epub 2015 May 8.58. Cheung, G.Y. Staphylococcus epidermidis strategies to avoid killing by humanneutrophils/ G.Y. Cheung, K. Rigby, R. Wang, S.Y. Queck, K.R. Braughton,118A.R. Whitney, M. Teintze, F.R. DeLeo, M. Otto, // PLoS Pathog. – 2010. – 6.e1001133.59. Cipriani, F.
Recent advances in epidemiology and prevention of atopic eczema /F. Cipriani, A. Dondi, G. Ricci // Pediatr Allergy Immunol. – 2014. – 25 (7). P.630–638.60. Cornelissen, C. IL-31 regulates differentiation and filaggrin expression in humanorganotypic skin models / C. Cornelissen, Y. Marquardt, K. Czaja, J. Wenzel, J.Frank, J. Luscher-Firzlaff, B. Luscher, J.M. Baron // J. Allergy Clin. Immunol. –2012. – 129. P.
426–433.61. Daniels, R. MicroSilver – An old active substance in new clothes/ R. Daniels, M.Mempel, M. Ulrich, P. Steinrücke // Pharmaceutical Journal. – 2009. – 4.62. de Haas, C. J. Chemotaxis inhibitory protein of Staphylococcus aureus, abacterial antiinflammatory agent/ C.J. de Haas, K.E.Veldkamp, A. Peschel, F.Weerkamp, W.J. Van Wamel, E.C. Heezius, M.J.
Poppelier, K.P. VanKessel, J.A. van Strijp // J Exp Med. – 2004. – Mar 1.199(5). P. 687-95.63. Deraison, C. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14and control desquamation through a pH-dependent interaction/ C. Deraison, C.Bonnart, F. Lopez, C. Besson, R. Robinson, A. Jayakumar et al. // Mol Biol Cell.– 2007.
– 18. P. 3607 -19.64. DiColandrea, T. Subcellular distribution of envoplakin and periplakin insightsinto their role as precursors of the epidermal cornified envelope/ T. DiColandrea,T. Karashima, A. Maatta, F.M. Watt // J Cell Biol. – 2000. – 151. P. 573-86.65. Diekema, D.J. Survey of infections due to Staphylococcus species: frequency ofoccurrence and antimicrobial susceptibility of isolates collected in the UnitedStates, Canada, Latin America, Europe, and the Western Pacific region for theSENTRY Antimicrobial Surveillance Program, 1997-1999 / D.J. Diekema, M.APfaller, F.J. Schmitz, J.
Smayevsky, J. Bell, R.N. Jones et al // Clin Infect Dis.– 2001. – 32. 2 P. 114–132.11966. Eckert, R.L. Transglutaminase function in epidermis / R.L. Eckert, M.T.Sturniolo, A.M. Broome, M. Ruse, E.A. Rorke // J Invest Dermatol. – 2005. –124. P. 481-92.67. Egawa, G. Barrier dysfunction in the skin allergy / G. Egawa, K.
Kabashima //Allergology International. – 2018. – 67. P. 3-11.68. Eigenmann, P.A. Prevalence of IgE-mediated food allergy among children withatopic dermatitis / P.A. Eigenmann, S.H. Sicherer, T.A. Borkowski, B.A. Cohen,H.A. Sampson // Pediatrics. – 1998. – 101. E8.69. Eissa, M.B.N. Molekularbiologischer Nachweis mutmaßlicher Virulenzfaktorenbei Staphylococcus aureus-Kulturen, isoliert von Rinder Mastitiden / Eissa,M.B.N. // Inaugural-Diss. Dr. Vet.
Med.Gie ßen. – 2007. – P. 187.70. Ekanayake-Mudiyanselage, S. Anwendungsbeobachtung mit topischensilberhaltigen Pflegeproduct (Multilind® MikroSilber Crème) zur Überprüfungder Wirksamkeit, Verträglichkeit und kosmetischen Akzeptanz beim atopischenEkzem. / S. Ekanayake-Mudiyanselage, A. Balk, V. Schoder, P. Hansen, W.Wigger-Alberti, K. Wilhelm // Kosmetische Medizin. – 2007. – 28(6).